Study analyzes the average inpatient care costs for COVID-19 patients, revealing significant variations in expenses across pandemic waves and patient demographics.
Eyenovia halts Phase 3 myopia trial, to consider selling assets
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS